TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Chiara Cremolini, Federica Marmorino, Fotios Loupakis, Gianluca Masi, Carlotta Antoniotti, Lisa Salvatore, Marta Schirripa, Luca Boni, Vittorina Zagonel, Sara Lonardi, Giuseppe Aprile, Emiliano Tamburini, Vincenzo Ricci, Monica Ronzoni, Filippo Pietrantonio, Chiara Valsuani, Gianluca Tomasello, Alessandro Passardi, Giacomo Allegrini, Samantha Di Donato, Daniele Santini, Alfredo Falcone, on behalf of all the investigators of the Gruppo Oncologico del Nord Ovest

ABSTRACT

BACKGROUND: Chemotherapy plus bevacizumab is a standard first-line treatment for unresectable metastatic colorectal cancer patients. Different chemotherapy backbones may be chosen, including one to three drugs, based on patients' general conditions and comorbidities, treatments' objectives, and disease characteristics. TRIBE trial demonstrated a significant advantage in terms of progression-free survival and overall survival for FOLFOXIRI plus bevacizumab as compared with FOLFIRI plus bevacizumab. Based on recent evidence, the de-intensification of the upfront regimen after 4-6 months of treatment is nowadays regarded as a valuable option. Moreover, the prolonged inhibition of angiogenesis, and in particular the continuation of bevacizumab beyond the evidence of disease progression, is an efficacious strategy in the treatment of metastatic colorectal cancer patients. METHODS/DESIGN: TRIBE-2 is a prospective, open-label, multicentric phase III randomized trial in which unresectable and previously untreated metastatic colorectal cancer patients are randomized to receive first-line FOLFOX plus bevacizumab followed by FOLFIRI plus bevacizumab after disease progression or FOLFOXIRI plus bevacizumab followed by the re-introduction of the same regimen after disease progression. The primary endpoint is to compare the efficacy of the two proposed treatment strategies in terms of Progression Free Survival 2. DISCUSSION: The TRIBE-2 study aims at answering the question whether the upfront use of FOLFOXIRI improves the clinical outcome of metastatic colorectal cancer patients, when compared with the pre-planned, sequential use of oxaliplatin-based and irinotecan-based doublets. Both proposed treatment strategies are designed to exploit the effectiveness of the prolonged inhibition of angiogenesis, alternating short (up to 4 months) induction periods and less intensive maintenance phases. TRIAL REGISTRATION: TRIBE2 is registered at Clinicaltrials.gov: NCT02339116 . January 12, 2015. TRIBE-2 is registered at EUDRACT 2014-004436-19, October 10, 2014. More... »

PAGES

408

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-017-3360-z

DOI

http://dx.doi.org/10.1186/s12885-017-3360-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085967974

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28599628


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cremolini", 
        "givenName": "Chiara", 
        "id": "sg:person.01257327771.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257327771.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marmorino", 
        "givenName": "Federica", 
        "id": "sg:person.0724557274.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724557274.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loupakis", 
        "givenName": "Fotios", 
        "id": "sg:person.01175106504.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175106504.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masi", 
        "givenName": "Gianluca", 
        "id": "sg:person.01062670207.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062670207.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Antoniotti", 
        "givenName": "Carlotta", 
        "id": "sg:person.0656444074.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656444074.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salvatore", 
        "givenName": "Lisa", 
        "id": "sg:person.01157052153.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157052153.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schirripa", 
        "givenName": "Marta", 
        "id": "sg:person.01225165353.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225165353.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliero-Universitaria Careggi", 
          "id": "https://www.grid.ac/institutes/grid.24704.35", 
          "name": [
            "Centro per il Coordinamento per le Sperimentazioni Cliniche, Istituto Toscano Tumori, AOU Careggi, viale Pieraccini 6, 50139, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boni", 
        "givenName": "Luca", 
        "id": "sg:person.01277427123.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277427123.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Oncologia Medica 1, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), via Gattamelata 64, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zagonel", 
        "givenName": "Vittorina", 
        "id": "sg:person.0622706463.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622706463.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Oncologico Veneto", 
          "id": "https://www.grid.ac/institutes/grid.419546.b", 
          "name": [
            "Oncologia Medica 1, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), via Gattamelata 64, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lonardi", 
        "givenName": "Sara", 
        "id": "sg:person.01155122733.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155122733.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aprile", 
        "givenName": "Giuseppe", 
        "id": "sg:person.01150115462.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150115462.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Infermi di Rimini", 
          "id": "https://www.grid.ac/institutes/grid.414614.2", 
          "name": [
            "Ospedale Infermi, Via Coriano 38, 47924, Rimini, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamburini", 
        "givenName": "Emiliano", 
        "id": "sg:person.01327330053.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327330053.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oncologia Medica, Dipartimento di Oncologia Clinica, Azienda Sanitaria Ospedaliera S. Croce, Via Michele Coppino 26, 12100, Cuneo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ricci", 
        "givenName": "Vincenzo", 
        "id": "sg:person.0722070557.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722070557.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "San Raffaele Hospital", 
          "id": "https://www.grid.ac/institutes/grid.18887.3e", 
          "name": [
            "Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ronzoni", 
        "givenName": "Monica", 
        "id": "sg:person.01213620671.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213620671.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Fondazione I.R.C.C.S, Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pietrantonio", 
        "givenName": "Filippo", 
        "id": "sg:person.01122027227.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122027227.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Dipartimento Oncologico, A.S.L. 1 Carrara, P.zza Sacco e Vanzetti, 2, 54033, Carrara, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valsuani", 
        "givenName": "Chiara", 
        "id": "sg:person.0670327042.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670327042.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "SC Oncologia, Istituti Ospedalieri Di Cremona, Viale Concordia 1, 26100, Cremona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomasello", 
        "givenName": "Gianluca", 
        "id": "sg:person.0637472115.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637472115.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Dipartimento di Oncologia Medica, IRCCS-IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), via Piero Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Passardi", 
        "givenName": "Alessandro", 
        "id": "sg:person.0650341574.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650341574.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oncologia Medica, Ospedale Felice Lotti, via Roma 147, 56025, Pontedera, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Allegrini", 
        "givenName": "Giacomo", 
        "id": "sg:person.0623002156.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623002156.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Dipartimento Oncologico, AUSL 4 Prato, Via Mazzamuti 7, 59100, Prato, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Donato", 
        "givenName": "Samantha", 
        "id": "sg:person.01057603421.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057603421.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Oncologia Medica, Universit\u00e0 Campus Bio-Medico, vai Alvaro del Portillo 200, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Santini", 
        "givenName": "Daniele", 
        "id": "sg:person.0700665677.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700665677.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Falcone", 
        "givenName": "Alfredo", 
        "id": "sg:person.01006230145.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006230145.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "on behalf of all the investigators of the Gruppo Oncologico del Nord Ovest", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2008.16.3212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003872431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004530593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70154-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005860041"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70477-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009666173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014051315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014381222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.3633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018213278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(15)00122-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019437953"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2015.129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020804628", 
          "https://doi.org/10.1038/nrclinonc.2015.129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021607564"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2015.399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022680969", 
          "https://doi.org/10.1038/bjc.2015.399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.5520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024553523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1403108", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025548121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.4344", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026343555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026558254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(14)62004-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029003642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdu260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029291056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.9930", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029489307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(15)00042-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036852730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70102-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048381204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdu580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053140905"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Chemotherapy plus bevacizumab is a standard first-line treatment for unresectable metastatic colorectal cancer patients. Different chemotherapy backbones may be chosen, including one to three drugs, based on patients' general conditions and comorbidities, treatments' objectives, and disease characteristics. TRIBE trial demonstrated a significant advantage in terms of progression-free survival and overall survival for FOLFOXIRI plus bevacizumab as compared with FOLFIRI plus bevacizumab. Based on recent evidence, the de-intensification of the upfront regimen after 4-6\u00a0months of treatment is nowadays regarded as a valuable option. Moreover, the prolonged inhibition of angiogenesis, and in particular the continuation of bevacizumab beyond the evidence of disease progression, is an efficacious strategy in the treatment of metastatic colorectal cancer patients.\nMETHODS/DESIGN: TRIBE-2 is a prospective, open-label, multicentric phase III randomized trial in which unresectable and previously untreated metastatic colorectal cancer patients are randomized to receive first-line FOLFOX plus bevacizumab followed by FOLFIRI plus bevacizumab after disease progression or FOLFOXIRI plus bevacizumab followed by the re-introduction of the same regimen after disease progression. The primary endpoint is to compare the efficacy of the two proposed treatment strategies in terms of Progression Free Survival 2.\nDISCUSSION: The TRIBE-2 study aims at answering the question whether the upfront use of FOLFOXIRI improves the clinical outcome of metastatic colorectal cancer patients, when compared with the pre-planned, sequential use of oxaliplatin-based and irinotecan-based doublets. Both proposed treatment strategies are designed to exploit the effectiveness of the prolonged inhibition of angiogenesis, alternating short (up to 4\u00a0months) induction periods and less intensive maintenance phases.\nTRIAL REGISTRATION: TRIBE2 is registered at Clinicaltrials.gov: NCT02339116 . January 12, 2015. TRIBE-2 is registered at EUDRACT 2014-004436-19, October 10, 2014.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-017-3360-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group", 
    "pagination": "408", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "956334d14e0d5f4799ade8b2f45799af32021e5ad36c18bff0bb37e959d16024"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28599628"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-017-3360-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085967974"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-017-3360-z", 
      "https://app.dimensions.ai/details/publication/pub.1085967974"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54331_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-017-3360-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3360-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3360-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3360-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3360-z'


 

This table displays all metadata directly associated to this object as RDF triples.

369 TRIPLES      21 PREDICATES      63 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-017-3360-z schema:about N1a61f71e29ce47d7be4f51cadb1b42a2
2 N3a9aa0e000ce4976a50d5d6f80132fd3
3 N7872b991a1284c8e8ff394d31f17ac96
4 N82b2006c82784465bf9310ac8f42ee41
5 N87ded1214d174e9cbbd938fb842d8a58
6 N95aa8bbd0ad14b30bb63eea9c1d25319
7 Na099c92199d94ab6a7db25f5c0875f36
8 Nb73c11730d1547e398aa9dcff5b5b932
9 Nc75b1883feb64e6fba5bb81786c23fe0
10 Nc9ac648b63ac4e199a74a0e913558366
11 Nc9f9da65fbab4844b8bddb96f3ab4659
12 Ne156cbaf603440e2bcf3d273ab55406c
13 Ne3df6e05a68a42f1b646d67417959fdb
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N1a47ee7bb56649478f64bea1a3164825
17 schema:citation sg:pub.10.1038/bjc.2015.399
18 sg:pub.10.1038/nrclinonc.2015.129
19 https://doi.org/10.1002/pds.3633
20 https://doi.org/10.1016/j.ejca.2008.10.026
21 https://doi.org/10.1016/s0140-6736(14)62004-3
22 https://doi.org/10.1016/s1470-2045(11)70102-4
23 https://doi.org/10.1016/s1470-2045(12)70477-1
24 https://doi.org/10.1016/s1470-2045(13)70154-2
25 https://doi.org/10.1016/s1470-2045(15)00042-x
26 https://doi.org/10.1016/s1470-2045(15)00122-9
27 https://doi.org/10.1056/nejmoa032691
28 https://doi.org/10.1056/nejmoa1403108
29 https://doi.org/10.1093/annonc/mdq580
30 https://doi.org/10.1093/annonc/mdu260
31 https://doi.org/10.1093/annonc/mdu580
32 https://doi.org/10.1093/annonc/mdv011
33 https://doi.org/10.1093/annonc/mdv012
34 https://doi.org/10.1200/jco.2007.14.9930
35 https://doi.org/10.1200/jco.2008.16.3212
36 https://doi.org/10.1200/jco.2009.23.4344
37 https://doi.org/10.1200/jco.2010.34.5520
38 schema:datePublished 2017-12
39 schema:datePublishedReg 2017-12-01
40 schema:description BACKGROUND: Chemotherapy plus bevacizumab is a standard first-line treatment for unresectable metastatic colorectal cancer patients. Different chemotherapy backbones may be chosen, including one to three drugs, based on patients' general conditions and comorbidities, treatments' objectives, and disease characteristics. TRIBE trial demonstrated a significant advantage in terms of progression-free survival and overall survival for FOLFOXIRI plus bevacizumab as compared with FOLFIRI plus bevacizumab. Based on recent evidence, the de-intensification of the upfront regimen after 4-6 months of treatment is nowadays regarded as a valuable option. Moreover, the prolonged inhibition of angiogenesis, and in particular the continuation of bevacizumab beyond the evidence of disease progression, is an efficacious strategy in the treatment of metastatic colorectal cancer patients. METHODS/DESIGN: TRIBE-2 is a prospective, open-label, multicentric phase III randomized trial in which unresectable and previously untreated metastatic colorectal cancer patients are randomized to receive first-line FOLFOX plus bevacizumab followed by FOLFIRI plus bevacizumab after disease progression or FOLFOXIRI plus bevacizumab followed by the re-introduction of the same regimen after disease progression. The primary endpoint is to compare the efficacy of the two proposed treatment strategies in terms of Progression Free Survival 2. DISCUSSION: The TRIBE-2 study aims at answering the question whether the upfront use of FOLFOXIRI improves the clinical outcome of metastatic colorectal cancer patients, when compared with the pre-planned, sequential use of oxaliplatin-based and irinotecan-based doublets. Both proposed treatment strategies are designed to exploit the effectiveness of the prolonged inhibition of angiogenesis, alternating short (up to 4 months) induction periods and less intensive maintenance phases. TRIAL REGISTRATION: TRIBE2 is registered at Clinicaltrials.gov: NCT02339116 . January 12, 2015. TRIBE-2 is registered at EUDRACT 2014-004436-19, October 10, 2014.
41 schema:genre research_article
42 schema:inLanguage en
43 schema:isAccessibleForFree true
44 schema:isPartOf Nafd3641e46bc4545b4bef38187f3ca9e
45 Nb43cfac4e4f94ba69d1f5a27085553a2
46 sg:journal.1024632
47 schema:name TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group
48 schema:pagination 408
49 schema:productId N2355bf4011e54e37a76108ebe6cf231f
50 N4339d4cb511e42f3bb8b1e26a3e9a21a
51 N4f803aa03b034af28f64c2b384c8feec
52 N7629ca3cb9b849a884680592bcabd363
53 Nb6958d12283e40399a25eef7951bb1d7
54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085967974
55 https://doi.org/10.1186/s12885-017-3360-z
56 schema:sdDatePublished 2019-04-11T10:20
57 schema:sdLicense https://scigraph.springernature.com/explorer/license/
58 schema:sdPublisher Ne56cd4712ecb4937a0306bef6064a50b
59 schema:url https://link.springer.com/10.1186%2Fs12885-017-3360-z
60 sgo:license sg:explorer/license/
61 sgo:sdDataset articles
62 rdf:type schema:ScholarlyArticle
63 N07a070972a46486cbc8335989ace54f5 rdf:first sg:person.0722070557.52
64 rdf:rest N3ad851a693f246c9b0515fc27022a611
65 N0d085b1319a9477fab6d90f4bbaef41d rdf:first N65ec2900473246bc896077d04c1b3888
66 rdf:rest rdf:nil
67 N0e26dc7a576241d1afa1e022937ea1c4 schema:name SC Oncologia, Istituti Ospedalieri Di Cremona, Viale Concordia 1, 26100, Cremona, Italy
68 rdf:type schema:Organization
69 N160450c67cd54c728d88b954f85a4885 schema:name Dipartimento Oncologico, AUSL 4 Prato, Via Mazzamuti 7, 59100, Prato, Italy
70 rdf:type schema:Organization
71 N1a47ee7bb56649478f64bea1a3164825 rdf:first sg:person.01257327771.59
72 rdf:rest N86105c3ee46a4cfcb4f2e7c071504625
73 N1a61f71e29ce47d7be4f51cadb1b42a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Bevacizumab
75 rdf:type schema:DefinedTerm
76 N1d6576f9ca574e36b6588effcaa3ac67 rdf:first sg:person.01006230145.44
77 rdf:rest N0d085b1319a9477fab6d90f4bbaef41d
78 N1e3eee71722b44b8bb114942a1c6cb33 rdf:first sg:person.01277427123.05
79 rdf:rest N351e94a6bf4248d0b6a96d5cd9a76c6b
80 N1fd853709a0c4aa68e3f1d888760ca6e schema:name Oncologia Medica, Dipartimento di Oncologia Clinica, Azienda Sanitaria Ospedaliera S. Croce, Via Michele Coppino 26, 12100, Cuneo, Italy
81 rdf:type schema:Organization
82 N2355bf4011e54e37a76108ebe6cf231f schema:name pubmed_id
83 schema:value 28599628
84 rdf:type schema:PropertyValue
85 N23874fed924b4ef5a5b136c120eded8b rdf:first sg:person.0700665677.08
86 rdf:rest N1d6576f9ca574e36b6588effcaa3ac67
87 N351e94a6bf4248d0b6a96d5cd9a76c6b rdf:first sg:person.0622706463.81
88 rdf:rest Nf85f38a4ecb5435c9b96ea33af9acb31
89 N399e2c9871504fca821d2d79f59368cf rdf:first sg:person.0656444074.77
90 rdf:rest N74ae729db0c94d8da941c9007d65940b
91 N3a9aa0e000ce4976a50d5d6f80132fd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Prospective Studies
93 rdf:type schema:DefinedTerm
94 N3ad851a693f246c9b0515fc27022a611 rdf:first sg:person.01213620671.55
95 rdf:rest N95b6996a597348808fa14867a5c209d4
96 N4339d4cb511e42f3bb8b1e26a3e9a21a schema:name dimensions_id
97 schema:value pub.1085967974
98 rdf:type schema:PropertyValue
99 N4f803aa03b034af28f64c2b384c8feec schema:name doi
100 schema:value 10.1186/s12885-017-3360-z
101 rdf:type schema:PropertyValue
102 N4fa76a83138b4cb19f4583af860836c9 schema:name Dipartimento di Oncologia Medica, IRCCS-IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), via Piero Maroncelli 40, 47014, Meldola, FC, Italy
103 rdf:type schema:Organization
104 N56f1fe73f00a4502b33f29b3cdcd42a4 rdf:first sg:person.0650341574.44
105 rdf:rest N74a547d6940c4fc28313ad62ecf78e01
106 N65ec2900473246bc896077d04c1b3888 schema:familyName on behalf of all the investigators of the Gruppo Oncologico del Nord Ovest
107 rdf:type schema:Person
108 N6cd48e96234d4643b6d4baace335f4b6 rdf:first sg:person.0637472115.75
109 rdf:rest N56f1fe73f00a4502b33f29b3cdcd42a4
110 N74a547d6940c4fc28313ad62ecf78e01 rdf:first sg:person.0623002156.45
111 rdf:rest Nc1160b3ca6f741b18ada11bfd9a20bc3
112 N74ae729db0c94d8da941c9007d65940b rdf:first sg:person.01157052153.90
113 rdf:rest Nc8a3d344a1c5434f9da73499556d6f1f
114 N7629ca3cb9b849a884680592bcabd363 schema:name nlm_unique_id
115 schema:value 100967800
116 rdf:type schema:PropertyValue
117 N7872b991a1284c8e8ff394d31f17ac96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Camptothecin
119 rdf:type schema:DefinedTerm
120 N82b2006c82784465bf9310ac8f42ee41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Colorectal Neoplasms
122 rdf:type schema:DefinedTerm
123 N86105c3ee46a4cfcb4f2e7c071504625 rdf:first sg:person.0724557274.89
124 rdf:rest Na889e9d2a0454f32825c4b10abd33686
125 N87ded1214d174e9cbbd938fb842d8a58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Disease-Free Survival
127 rdf:type schema:DefinedTerm
128 N95aa8bbd0ad14b30bb63eea9c1d25319 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Leucovorin
130 rdf:type schema:DefinedTerm
131 N95b6996a597348808fa14867a5c209d4 rdf:first sg:person.01122027227.93
132 rdf:rest Nfbd3beb976c1474d83cebd73dc223b0e
133 Na099c92199d94ab6a7db25f5c0875f36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Treatment Outcome
135 rdf:type schema:DefinedTerm
136 Na889e9d2a0454f32825c4b10abd33686 rdf:first sg:person.01175106504.32
137 rdf:rest Nc101bd31efc741d6b7cd52cd69a4b99e
138 Nafd3641e46bc4545b4bef38187f3ca9e schema:volumeNumber 17
139 rdf:type schema:PublicationVolume
140 Nb43cfac4e4f94ba69d1f5a27085553a2 schema:issueNumber 1
141 rdf:type schema:PublicationIssue
142 Nb6958d12283e40399a25eef7951bb1d7 schema:name readcube_id
143 schema:value 956334d14e0d5f4799ade8b2f45799af32021e5ad36c18bff0bb37e959d16024
144 rdf:type schema:PropertyValue
145 Nb73c11730d1547e398aa9dcff5b5b932 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Research Design
147 rdf:type schema:DefinedTerm
148 Nbebd20a84395405b8c896488ead1d346 rdf:first sg:person.01150115462.24
149 rdf:rest Ned2d919219b84aad805111e12b98509a
150 Nc101bd31efc741d6b7cd52cd69a4b99e rdf:first sg:person.01062670207.83
151 rdf:rest N399e2c9871504fca821d2d79f59368cf
152 Nc1160b3ca6f741b18ada11bfd9a20bc3 rdf:first sg:person.01057603421.45
153 rdf:rest N23874fed924b4ef5a5b136c120eded8b
154 Nc45f431517b14a63a36c74f8713c3498 schema:name Dipartimento Oncologico, A.S.L. 1 Carrara, P.zza Sacco e Vanzetti, 2, 54033, Carrara, Italy
155 rdf:type schema:Organization
156 Nc75b1883feb64e6fba5bb81786c23fe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Organoplatinum Compounds
158 rdf:type schema:DefinedTerm
159 Nc8a3d344a1c5434f9da73499556d6f1f rdf:first sg:person.01225165353.57
160 rdf:rest N1e3eee71722b44b8bb114942a1c6cb33
161 Nc9ac648b63ac4e199a74a0e913558366 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Fluorouracil
163 rdf:type schema:DefinedTerm
164 Nc9f9da65fbab4844b8bddb96f3ab4659 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Antineoplastic Combined Chemotherapy Protocols
166 rdf:type schema:DefinedTerm
167 Ne156cbaf603440e2bcf3d273ab55406c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Humans
169 rdf:type schema:DefinedTerm
170 Ne3df6e05a68a42f1b646d67417959fdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Neoplasm Metastasis
172 rdf:type schema:DefinedTerm
173 Ne56cd4712ecb4937a0306bef6064a50b schema:name Springer Nature - SN SciGraph project
174 rdf:type schema:Organization
175 Ne9e30d5463d64ec58886b98028bb3279 schema:name Oncologia Medica, Ospedale Felice Lotti, via Roma 147, 56025, Pontedera, Italy
176 rdf:type schema:Organization
177 Ned2d919219b84aad805111e12b98509a rdf:first sg:person.01327330053.68
178 rdf:rest N07a070972a46486cbc8335989ace54f5
179 Nf85f38a4ecb5435c9b96ea33af9acb31 rdf:first sg:person.01155122733.59
180 rdf:rest Nbebd20a84395405b8c896488ead1d346
181 Nfbd3beb976c1474d83cebd73dc223b0e rdf:first sg:person.0670327042.87
182 rdf:rest N6cd48e96234d4643b6d4baace335f4b6
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
187 schema:name Oncology and Carcinogenesis
188 rdf:type schema:DefinedTerm
189 sg:journal.1024632 schema:issn 1471-2407
190 schema:name BMC Cancer
191 rdf:type schema:Periodical
192 sg:person.01006230145.44 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
193 schema:familyName Falcone
194 schema:givenName Alfredo
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006230145.44
196 rdf:type schema:Person
197 sg:person.01057603421.45 schema:affiliation N160450c67cd54c728d88b954f85a4885
198 schema:familyName Di Donato
199 schema:givenName Samantha
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057603421.45
201 rdf:type schema:Person
202 sg:person.01062670207.83 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
203 schema:familyName Masi
204 schema:givenName Gianluca
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062670207.83
206 rdf:type schema:Person
207 sg:person.01122027227.93 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
208 schema:familyName Pietrantonio
209 schema:givenName Filippo
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122027227.93
211 rdf:type schema:Person
212 sg:person.01150115462.24 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
213 schema:familyName Aprile
214 schema:givenName Giuseppe
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150115462.24
216 rdf:type schema:Person
217 sg:person.01155122733.59 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
218 schema:familyName Lonardi
219 schema:givenName Sara
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155122733.59
221 rdf:type schema:Person
222 sg:person.01157052153.90 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
223 schema:familyName Salvatore
224 schema:givenName Lisa
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157052153.90
226 rdf:type schema:Person
227 sg:person.01175106504.32 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
228 schema:familyName Loupakis
229 schema:givenName Fotios
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175106504.32
231 rdf:type schema:Person
232 sg:person.01213620671.55 schema:affiliation https://www.grid.ac/institutes/grid.18887.3e
233 schema:familyName Ronzoni
234 schema:givenName Monica
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213620671.55
236 rdf:type schema:Person
237 sg:person.01225165353.57 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
238 schema:familyName Schirripa
239 schema:givenName Marta
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225165353.57
241 rdf:type schema:Person
242 sg:person.01257327771.59 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
243 schema:familyName Cremolini
244 schema:givenName Chiara
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257327771.59
246 rdf:type schema:Person
247 sg:person.01277427123.05 schema:affiliation https://www.grid.ac/institutes/grid.24704.35
248 schema:familyName Boni
249 schema:givenName Luca
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277427123.05
251 rdf:type schema:Person
252 sg:person.01327330053.68 schema:affiliation https://www.grid.ac/institutes/grid.414614.2
253 schema:familyName Tamburini
254 schema:givenName Emiliano
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327330053.68
256 rdf:type schema:Person
257 sg:person.0622706463.81 schema:affiliation https://www.grid.ac/institutes/grid.419546.b
258 schema:familyName Zagonel
259 schema:givenName Vittorina
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622706463.81
261 rdf:type schema:Person
262 sg:person.0623002156.45 schema:affiliation Ne9e30d5463d64ec58886b98028bb3279
263 schema:familyName Allegrini
264 schema:givenName Giacomo
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623002156.45
266 rdf:type schema:Person
267 sg:person.0637472115.75 schema:affiliation N0e26dc7a576241d1afa1e022937ea1c4
268 schema:familyName Tomasello
269 schema:givenName Gianluca
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637472115.75
271 rdf:type schema:Person
272 sg:person.0650341574.44 schema:affiliation N4fa76a83138b4cb19f4583af860836c9
273 schema:familyName Passardi
274 schema:givenName Alessandro
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650341574.44
276 rdf:type schema:Person
277 sg:person.0656444074.77 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
278 schema:familyName Antoniotti
279 schema:givenName Carlotta
280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656444074.77
281 rdf:type schema:Person
282 sg:person.0670327042.87 schema:affiliation Nc45f431517b14a63a36c74f8713c3498
283 schema:familyName Valsuani
284 schema:givenName Chiara
285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670327042.87
286 rdf:type schema:Person
287 sg:person.0700665677.08 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
288 schema:familyName Santini
289 schema:givenName Daniele
290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700665677.08
291 rdf:type schema:Person
292 sg:person.0722070557.52 schema:affiliation N1fd853709a0c4aa68e3f1d888760ca6e
293 schema:familyName Ricci
294 schema:givenName Vincenzo
295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722070557.52
296 rdf:type schema:Person
297 sg:person.0724557274.89 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
298 schema:familyName Marmorino
299 schema:givenName Federica
300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724557274.89
301 rdf:type schema:Person
302 sg:pub.10.1038/bjc.2015.399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022680969
303 https://doi.org/10.1038/bjc.2015.399
304 rdf:type schema:CreativeWork
305 sg:pub.10.1038/nrclinonc.2015.129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020804628
306 https://doi.org/10.1038/nrclinonc.2015.129
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1002/pds.3633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018213278
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1016/j.ejca.2008.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026558254
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1016/s0140-6736(14)62004-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029003642
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1016/s1470-2045(11)70102-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048381204
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1016/s1470-2045(12)70477-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009666173
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1016/s1470-2045(13)70154-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005860041
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1016/s1470-2045(15)00042-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036852730
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1016/s1470-2045(15)00122-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019437953
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1056/nejmoa032691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014051315
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1056/nejmoa1403108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025548121
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1093/annonc/mdq580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014381222
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1093/annonc/mdu260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029291056
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1093/annonc/mdu580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053140905
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1093/annonc/mdv011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021607564
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1093/annonc/mdv012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004530593
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1200/jco.2007.14.9930 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029489307
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1200/jco.2008.16.3212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003872431
341 rdf:type schema:CreativeWork
342 https://doi.org/10.1200/jco.2009.23.4344 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026343555
343 rdf:type schema:CreativeWork
344 https://doi.org/10.1200/jco.2010.34.5520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024553523
345 rdf:type schema:CreativeWork
346 https://www.grid.ac/institutes/grid.144189.1 schema:alternateName Azienda Ospedaliera Universitaria Pisana
347 schema:name Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy
348 rdf:type schema:Organization
349 https://www.grid.ac/institutes/grid.18887.3e schema:alternateName San Raffaele Hospital
350 schema:name Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy
351 rdf:type schema:Organization
352 https://www.grid.ac/institutes/grid.24704.35 schema:alternateName Azienda Ospedaliero-Universitaria Careggi
353 schema:name Centro per il Coordinamento per le Sperimentazioni Cliniche, Istituto Toscano Tumori, AOU Careggi, viale Pieraccini 6, 50139, Florence, Italy
354 rdf:type schema:Organization
355 https://www.grid.ac/institutes/grid.411492.b schema:alternateName Ospedale Santa Maria della Misericordia di Udine
356 schema:name Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy
357 rdf:type schema:Organization
358 https://www.grid.ac/institutes/grid.414614.2 schema:alternateName Ospedale Infermi di Rimini
359 schema:name Ospedale Infermi, Via Coriano 38, 47924, Rimini, Italy
360 rdf:type schema:Organization
361 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
362 schema:name Fondazione I.R.C.C.S, Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy
363 rdf:type schema:Organization
364 https://www.grid.ac/institutes/grid.419546.b schema:alternateName Istituto Oncologico Veneto
365 schema:name Oncologia Medica 1, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), via Gattamelata 64, 35128, Padua, Italy
366 rdf:type schema:Organization
367 https://www.grid.ac/institutes/grid.9657.d schema:alternateName Università Campus Bio-Medico
368 schema:name Oncologia Medica, Università Campus Bio-Medico, vai Alvaro del Portillo 200, 00128, Rome, Italy
369 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...